Clinical Trial

HEP® Delivered Via Telerehabilitation for Preterm Infants With Developmental Risks

Study acronym: HEP-Preterm
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2026 (before its estimated August 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
Preterm infants are at increased risk for developmental delays, making early intervention essential for optimizing developmental outcomes. This study aims to evaluate the effectiveness of the Homeostasis-Enrichment-Plasticity (HEP®) approach delivered via telerehabilitation in preterm infants at risk for developmental delay. Eligible preterm infants will be randomly assigned to either the HEP® telerehabilitation group or the control group receiving usual care. The intervention will be delivered over 12 weeks through weekly online sessions combined with parent coaching and individualized home-based activities. The study will evaluate the effects of the intervention on infant development, sensory functions, goal attainment, and parental well-being. The findings may provide evidence for the use of family-centered telerehabilitation as an early intervention strategy for preterm infants at developmental risk.
Trial Details
NCT Number NCT07725367
Lead Sponsor Medipol University
Conditions Prematurity, Developmental Delays
Enrollment 32 participants
Start Date 2026-02-05
Primary Completion 2026-08-05 (estimated)
Study Completion 2026-08-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-24